Consonance Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,314,421
Closed -$33.8M 36
2020
Q1
$33.8M Hold
2,314,421
2.51% 18
2019
Q4
$32.9M Hold
2,314,421
2.01% 20
2019
Q3
$26.8M Sell
2,314,421
-1,498,095
-39% -$17.4M 2.65% 17
2019
Q2
$76.6M Sell
3,812,516
-219,607
-5% -$4.41M 5.42% 5
2019
Q1
$91.2M Hold
4,032,123
5.76% 6
2018
Q4
$91.2M Buy
4,032,123
+117,941
+3% +$2.67M 6.71% 6
2018
Q3
$112M Buy
3,914,182
+70,811
+2% +$2.03M 6.05% 2
2018
Q2
$105M Buy
3,843,371
+150,000
+4% +$4.09M 6.76% 4
2018
Q1
$82.6M Buy
3,693,371
+48,933
+1% +$1.09M 7.55% 4
2017
Q4
$76.8M Buy
3,644,438
+138,834
+4% +$2.93M 6.94% 6
2017
Q3
$87.3M Buy
3,505,604
+1,067,064
+44% +$26.6M 9.65% 2
2017
Q2
$47.3M Buy
2,438,540
+306,400
+14% +$5.94M 5.57% 11
2017
Q1
$39.4M Sell
2,132,140
-640,016
-23% -$11.8M 4.13% 13
2016
Q4
$52.5M Sell
2,772,156
-312,791
-10% -$5.92M 5.76% 6
2016
Q3
$69M Buy
3,084,947
+385,000
+14% +$8.62M 6.65% 6
2016
Q2
$48.1M Sell
2,699,947
-30,000
-1% -$534K 6.81% 6
2016
Q1
$37.3M Sell
2,729,947
-730,376
-21% -$9.98M 5.64% 10
2015
Q4
$66.8M Buy
3,460,323
+10,000
+0.3% +$193K 8.95% 6
2015
Q3
$69.9M Buy
3,450,323
+50,000
+1% +$1.01M 9.84% 4
2015
Q2
$113M Buy
3,400,323
+292,613
+9% +$9.7M 11.33% 1
2015
Q1
$74.5M Buy
3,107,710
+556,175
+22% +$13.3M 6.78% 6
2014
Q4
$31.2M Buy
2,551,535
+1,012,076
+66% +$12.4M 4.02% 11
2014
Q3
$13.9M Buy
+1,539,459
New +$13.9M 1.91% 18